John De Groot, MD
Professor
Neurology
School of Medicine
Publications (8)
Top publication keywords:
Cell NucleusBrain NeoplasmsNeoplasm Recurrence, LocalPTEN PhosphohydrolaseGliomaAntibodies, Monoclonal, HumanizedRadiation ToleranceNeoplasm MetastasisGlioblastomaSurvival RateAngiogenesis InhibitorsReceptor, Fibroblast Growth Factor, Type 2BevacizumabClinical Trials as TopicDisease-Free Survival
-
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Neuro-oncology 2025 Wen PY, Weller M, Lee EQ, Touat M, Khasraw M, Rahman R, Platten M, Lim M, Winkler F, Horbinski C, Verhaak RGW, Huang RY, Ahluwalia MS, Albert NL, Tonn JC, Schiff D, Barnholtz-Sloan JS, Ostrom Q, … -
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
Cancer cell 2019 Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, Gahman TC, Shiau AK, Zhou H, … -
Profiles of brain metastases: Prioritization of therapeutic targets.
International journal of cancer 2018 Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, … -
Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.
Neuro-oncology 2014 Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, Sarkaria JN, Tawab-Amiri A,… -
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
Journal of neuro-oncology 2014 Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF -
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, … -
Clinical trial end points for high-grade glioma: the evolving landscape.
Neuro-oncology 2011 Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen … -
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van…